|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1211 Medical Center Drive |
Address2 | Suite D-3300 MCN |
City | Nashville |
State | TN |
Zip Code | 37232 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401104096-12
|
||||||||
|
6. House ID# 433060001
|
TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: John Manning |
Date | 4/22/2024 5:15:14 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S.2624/H.R.5894, the FY 2024 Labor-HHS-Education appropriations bill
S.2127/H.R.4366, the FY 2024 MilCon-VA appropriations bill, provisions related to VA Medical Research.
H.R.2882, the FY24 Further Consolidated Appropriations Act, provisions related to biomedical research, public health, and healthcare operations.
H.R.4366, the FY2024 Consolidated Appropriations Act, provisions related to VA research and healthcare operations.
Issues related to FY24 and FY25 funding for NIH.
Issues related to FY24 and FY25 funding for VA Medical Research.
Issues related to FY24 funding for AHRQ.
Issues related to the NIH All of Us Research Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexander |
Currie |
|
Vice President, VUMC Federal Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S.2768/H.R.2584, the SAVE Act, issues related to violence against health care providers.
H.R.5378, Lower Costs, More Transparency Act, issues related to reimbursement cuts and administrative burdens on hospitals.
S.765/H.R.1526, the Reducing Hereditary Cancers Act.
H.R.4286, the Increasing Access to Lung Cancer Screening Act.
H.R.1711/S.940, the Rural America Health Corps Act.
S.3765/H.R.6960, the Emergency Medical Services for Children Reauthorization Act of 2024
H.R.7251, the Poison Control Centers Reauthorization Act of 2024
Issues related to information blocking rule.
Issues related to solid organ transplantation and OPTN reforms.
Issues related to regulation of laboratory developed tests.
Issues related to the expansion of telehealth services.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexander |
Currie |
|
Vice President, VUMC Federal Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S.2624/H.R.5894, the FY 2024 Labor-HHS-Education appropriations bill
S.2127/H.R.4366, the FY 2024 MilCon-VA appropriations bill, provisions related to VA Medical Research.
H.R.2882, the FY24 Further Consolidated Appropriations Act, provisions related to biomedical research funding.
H.R.4366, the FY2024 Consolidated Appropriations Act, provisions related to VA research funding.
Issues related to the NIH All of Us Research Program
Issues related to FY24 and FY25 funding for NIH.
Issues related to FY24 and FY25 funding for VA Medical Research.
Issues related to FY24 funding for AHRQ.
Issues related to FY24 funding for Alzheimers disease research
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexander |
Currie |
|
Vice President, VUMC Federal Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S.803/H.R.3635, Save Rural Hospitals Act of 2023, issues related to area wage index reform.
H.R.5378, Lower Costs, More Transparency Act, issues related to reimbursement cuts and administrative burdens on hospitals.
S.1302/H.R.2389, the Resident Physician Shortage Reduction Act.
H.R.4286, the Increasing Access to Lung Cancer Screening Act.
Issues related to CMS telehealth policies.
Issues related to Medicares hospital at home programs.
Issues related to Medicare geographic reclassification.
Issues related to hospital outpatient reimbursement.
Issues related to clinician payment under the Medicare Physician Fee Schedule.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexander |
Currie |
|
Vice President, VUMC Federal Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues related to the 340B discount drug program.
Issues related to drug shortages.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexander |
Currie |
|
Vice President, VUMC Federal Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |